Genzyme Corporation Cambridge, MA - 02142

Genzyme Corporation is categorized under Enzyme and Isoenzyme Diagnostic Agents in Cambridge, MA and active since 2011.

Genzyme Corporation was established in 2011, and today employs 1 to 4, earning Over $1 Billion per year. This is a Enzyme and Isoenzyme Diagnostic Agents business, which does work in the B2B market, and is classified as a Enzyme and Isoenzyme Diagnostic Agents, under code number 325412 by the NAICS.

If you are seeking more information, feel free to contact David Meeker at the company’s headquarters by writing to 500 Kendall St, Cambridge, Massachusetts MA 02142 or by phoning (617) 252-7500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genzyme Corporation
Contact Person: David Meeker
Address: 500 Kendall St, Cambridge, Massachusetts 02142
Phone Number: (617) 252-7500
Website Address: news.genzyme.com
Annual Revenue (USD): Over $1 Billion
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Enzyme and Isoenzyme Diagnostic Agents
SIC Code: 2835
NAICS Code: 325412
Share This Business:

Genzyme Corporation was started in 2011 to provide professional Enzyme and Isoenzyme Diagnostic Agents under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Over $1 Billion per annum.

Feel free to contact David Meeker for inquiries that concern Genzyme Corporation by calling the company number (617) 252-7500, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Genzyme Corporation can be found at the coordinates 42.364142,-71.081644 as well as the street address 500 Kendall St in Cambridge, Massachusetts 02142.

For its online presence, you may visit Genzyme Corporation’s website at news.genzyme.com and engage with its social media outlets through on Twitter and on Facebook.